Skip to content
Screener

Rapport Therapeutics, Inc. RAPP Professional And Consulting Costs — Selling General And Administrative Expense

Other product segments

Facility Related And Other
$844K-0.8%

Similar metrics at other companies

Flowers Foods logo
FLOWorkforce Related Costs Selling Distribution And Administrative Expenses — Selling General And Administrative Expense
$211.71M+4.5%
Flowers Foods logo
FLOOther Selling Distribution And Administrative Expenses — Selling General And Administrative Expense
$250.56M+5.3%
Flexible Solutions International logo
FSISelling General And Administrative Expense
$762.36K+0.8%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%
Armstrong World Industries logo
AWIMineral Fiber — Selling General And Administrative Expense
$48.7M+10.7%
GCO
GCORetail Occupancy Costs — Selling General And Administrative Expense
$74.1M+1.0%

Other financials

Income statement

See full
Revenue-
Operating income-$60.8M-106%
Net income-$56.6M-112%
EPS (diluted)-$1.19-58.7%

Balance sheet

See full
Cash & equivalents$63.6M+15.5%
Total debt$10.1M-14.8%
Total equity$422.9M+60.5%
Total assets$459.0M+60.8%

Cash flow

See full
Operating cash flow-$41.5M-65.4%
CapEx$78.0K+255%
Free cash flow-$41.5M-65.5%

Valuation

See full
Market cap$2.18B+319%
Enterprise value$2.13B+345%
P/S109.1×

Profitability

See full
Operating margin-767.6%
Net margin-685.8%
FCF margin-485.7%

Returns & leverage

See full
Return on equity-40%+22.3pp
Debt / equity0.0×
Current ratio15.7×-7.0×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333862
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For The Six Months Ended June 30, 2026For The Six Months Ended June 30, 2025
Collaboration revenue$20,000
Operating expenses
Research and development51,41422,68084,13042,252
Selling, general and administrative9,3926,81620,89114,352
Total operating expenses60,80629,496105,02156,604
Loss from operations(60,806)(29,496)(85,021)(56,604)
Other income:
Interest income4,1912,7648,5495,809

Item 1. Financial Statements.

FAQ

What is Rapport Therapeutics, Inc.'s professional and consulting costs — selling general and administrative expense?
Rapport Therapeutics, Inc. (RAPP) reported professional and consulting costs — selling general and administrative expense of $1.46M in Q2 2026.
What does professional and consulting costs — selling general and administrative expense mean?
This metric represents the portion of selling, general, and administrative expenses allocated to external professional services and consulting engagements. It captures the costs associated with third-party expertise required to support commercialization efforts, market research, and business development activities. Monitoring this spend helps investors assess the company's investment in external support for scaling operations and market entry strategies.

Ask your AI about Rapport Therapeutics, Inc.'s professional and consulting costs — selling general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude